Dr. James H. Flory, MD
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
- Medicare participating
At a glance
- Medical school
- Perelman School of Med at the University of Pennsylvania (2009)
- Years since graduation
- 17
- In the NPI registry since
- 2009
- Medicare patients seen, 2024
- 207
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2009Medical school: Perelman School of Med at the University of Pennsylvania
- 2009Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
NY license 262997
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Memorial Endocrine Group (19 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 207
- Services billed
- 336
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 156 | 82 |
| Established patient office or other outpatient visit, 20-29 minutes | 66 | 53 |
| New patient office or other outpatient visit, 45-59 minutes | 35 | 35 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 15 | 12 |
| New patient office or other outpatient visit, 30-44 minutes | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Glipizide Er (glipizide) Other prescribers in New York, NY | 278 |
| Metformin Hcl Er (metformin hcl) Other prescribers in New York, NY | 147 |
| Jardiance (empagliflozin) Other prescribers in New York, NY | 99 |
| Ozempic (semaglutide) Other prescribers in New York, NY | 82 |
| Lantus Solostar (insulin glargine,hum.rec.anlog) Other prescribers in New York, NY | 78 |
| Levothyroxine Sodium Other prescribers in New York, NY | 71 |
| Nano 2nd Gen Pen Needle (pen needle, diabetic) Other prescribers in New York, NY | 56 |
| Mounjaro (tirzepatide) Other prescribers in New York, NY | 50 |
| Metformin Hcl Other prescribers in New York, NY | 48 |
| Januvia (sitagliptin phosphate) Other prescribers in New York, NY | 34 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $826 in total to this clinician.
| Fresenius Kabi USA, LLC | $826 |
|---|
| Travel and Lodging | $826 |
|---|
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Fresenius Kabi USA, LLC Apr 21, 2025 | Travel and Lodging Tyenne · Biosimilars · travel to Washington, DC · in-kind | $826 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.